One of the discrepancies between studies on breast cancer, including EMT, concerns differently described MDA-MB-231 cell lines, reported as either of epithelial phenotype (with detectable E-cadherin) or mesenchymal origin. This evidence concerns the gene CDH1 and breast carcinoma.